LYRA
NASDAQ
$0.52
Lyra Therapeutics Inc (LYRA)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$927K
Price Chart
Valuation
Market Cap$927K
Profitability
Total Revenue (TTM)$398K
Gross Profit (TTM)-$20M
EBITDA-$31M
EPS-$18.62
Growth & Risk
FCF 5Y CAGR+8.34%
Sharpe Ratio-1.19